Lansoprazole Eg

Lansoprazole, the active ingredient in Lansoprazole EG, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults. GNH USA supplies Lansoprazole EG as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway, providing relief in several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation by lowering stomach acidity. - Peptic ulcer disease: promotes ulcer healing by reducing acid exposure to the gastric mucosa. - Helicobacter pylori eradication: used in combination regimens to increase eradication rates. - Erosive esophagitis: heals inflamed esophageal tissue by maintaining a less acidic environment.

Lansoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, usually transient. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: abnormal liver function tests. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

Before initiating therapy with Lansoprazole, consider the following safety measures. - Assess renal function: adjust use in severe kidney impairment. - Evaluate hepatic status: use cautiously in liver disease. - Review long‑term use: monitor for osteoporosis or fractures. - Check for infections: be alert to signs of C. difficile colitis. - Pregnancy and lactation: discuss risks with a healthcare professional. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Lansoprazole may alter the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Antifungal agents (e.g., ketoconazole, itraconazole): reduced absorption and efficacy. - HIV protease inhibitors (e.g., atazanavir): markedly decreased plasma levels. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation. - Digoxin: possible increase in serum concentration. - Methotrexate (high dose): reduced clearance, monitor toxicity. - Diazepam: increased sedation, observe clinical response.